imipramine has been researched along with Migraine Disorders in 11 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated platelet 3H-imipramine (3H-IMI) binding, a putative peripheral serotonergic marker, and the activity of sulphotransferase (ST), an enzyme involved in the catabolism of catecholamines and phenolic compounds, in 14 patients suffering from migraine without aura (MWoA) and in 10 with tension-type headache (TH), as compared with a group of controls." | 7.69 | Platelet 3H-imipramine binding and sulphotransferase activity in primary headache. ( Bonuccelli, U; Cassano, GB; Lucetti, C; Marazziti, D; Muratorio, A; Nuti, A; Palego, L; Pavese, N; Pedri, S; Toni, C, 1994) |
| "Platelet [3H]imipramine binding was measured in 40 migrainous (7 classical and 33 common) and 17 tension headache patients and in 28 normal controls." | 7.68 | Platelet [3H]imipramine binding in migraine and tension headache in relation to depression. ( Davies, PT; Fernandez, M; Glover, V; Jarman, J; Rose, FC; Sandler, M; Steiner, TJ, 1991) |
| "We investigated platelet 3H-imipramine (3H-IMI) binding, a putative peripheral serotonergic marker, and the activity of sulphotransferase (ST), an enzyme involved in the catabolism of catecholamines and phenolic compounds, in 14 patients suffering from migraine without aura (MWoA) and in 10 with tension-type headache (TH), as compared with a group of controls." | 3.69 | Platelet 3H-imipramine binding and sulphotransferase activity in primary headache. ( Bonuccelli, U; Cassano, GB; Lucetti, C; Marazziti, D; Muratorio, A; Nuti, A; Palego, L; Pavese, N; Pedri, S; Toni, C, 1994) |
| "Platelet [3H]imipramine binding was measured in 40 migrainous (7 classical and 33 common) and 17 tension headache patients and in 28 normal controls." | 3.68 | Platelet [3H]imipramine binding in migraine and tension headache in relation to depression. ( Davies, PT; Fernandez, M; Glover, V; Jarman, J; Rose, FC; Sandler, M; Steiner, TJ, 1991) |
| "Migraine burden of migraines with brainstem aura, hemiplegic migraines, and retinal migraine was assessed using the Headache Impact Test-6™ (HIT-6) and the Pediatric Migraine Disability Assessment scale (PedMIDAS)." | 1.56 | Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine. ( Daida, A; Go, S; Ishida, Y; Kashiwagi, Y; Kasuga, A; Kawashima, H; Morichi, S; Morishita, N; Nagao, R; Oana, S; Suganami, Y; Suzuki, S; Takeshita, M; Tomoko, T; Yamanaka, G, 2020) |
| "A family history of migraine, primarily maternal, was found in 11 of 12 patients in whom it could be evaluated." | 1.29 | Migraine in the infant and toddler. ( Barlow, CF, 1994) |
| "psychogenic dissociation is considered." | 1.28 | Organic dissociative syndrome associated with antimigraine pharmacotherapy. ( Good, MI, 1991) |
| "The infants with ophthalmoplegic migraine failed to completely respond to any therapy." | 1.28 | Migraine headache in the infant and young child. ( Elser, JM; Woody, RC, 1990) |
| "Patients with classical migraine investigated between attacks had significantly fewer platelet 3H-imipramine binding sites than control subjects and this finding was more marked in males than in females." | 1.27 | Decreased platelet 3H-imipramine binding sites in classical migraine. ( Elliott, JM; Geaney, DP; Grahame-Smith, DG; Peet, KM; Rutterford, MG; Schächter, M, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Yamanaka, G | 1 |
| Go, S | 1 |
| Morichi, S | 1 |
| Takeshita, M | 1 |
| Morishita, N | 1 |
| Suzuki, S | 1 |
| Tomoko, T | 1 |
| Kasuga, A | 1 |
| Daida, A | 1 |
| Ishida, Y | 1 |
| Oana, S | 1 |
| Suganami, Y | 1 |
| Nagao, R | 1 |
| Kashiwagi, Y | 1 |
| Kawashima, H | 1 |
| Nagata, E | 1 |
| Geaney, DP | 1 |
| Rutterford, MG | 1 |
| Elliott, JM | 1 |
| Schächter, M | 1 |
| Peet, KM | 1 |
| Grahame-Smith, DG | 1 |
| Marazziti, D | 1 |
| Bonuccelli, U | 1 |
| Nuti, A | 1 |
| Toni, C | 1 |
| Pedri, S | 1 |
| Palego, L | 1 |
| Pavese, N | 1 |
| Lucetti, C | 1 |
| Muratorio, A | 1 |
| Cassano, GB | 1 |
| Barlow, CF | 1 |
| Pukhal'skaia, TG | 1 |
| Kolosova, OA | 1 |
| Men'shikov, MIu | 1 |
| Ellman, SJ | 1 |
| Arkin, AM | 1 |
| Nelson, WT | 1 |
| Steiner, SS | 1 |
| Jarman, J | 1 |
| Davies, PT | 1 |
| Fernandez, M | 1 |
| Glover, V | 1 |
| Steiner, TJ | 1 |
| Rose, FC | 1 |
| Sandler, M | 1 |
| Good, MI | 1 |
| Elser, JM | 1 |
| Woody, RC | 1 |
| Wormser, P | 1 |
1 review available for imipramine and Migraine Disorders
| Article | Year |
|---|---|
[Antidepressants in migraine prophylaxis].
Topics: Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Depression; Drug Administration Sche | 2009 |
10 other studies available for imipramine and Migraine Disorders
| Article | Year |
|---|---|
Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine.
Topics: Adolescent; Brain; Brain Stem; Child; Cost of Illness; Domperidone; Electrocardiography; Electroence | 2020 |
Decreased platelet 3H-imipramine binding sites in classical migraine.
Topics: Blood Platelets; Carrier Proteins; Female; Humans; Imipramine; Kinetics; Lysergic Acid Diethylamide; | 1984 |
Platelet 3H-imipramine binding and sulphotransferase activity in primary headache.
Topics: Adolescent; Adult; Arylsulfotransferase; Blood Platelets; Carrier Proteins; Female; Headache; Humans | 1994 |
Migraine in the infant and toddler.
Topics: Adolescent; Amitriptyline; Child; Child, Preschool; Diagnosis, Differential; Electroencephalography; | 1994 |
[Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
Topics: Blood Platelets; Humans; Imipramine; In Vitro Techniques; Male; Migraine Disorders; Platelet Aggrega | 1998 |
Sleep-related periodic headache and imipramine.
Topics: Adult; Chronic Disease; Female; Humans; Imipramine; Male; Migraine Disorders; Sleep, REM | 1976 |
Platelet [3H]imipramine binding in migraine and tension headache in relation to depression.
Topics: Adult; Anxiety; Blood Platelets; Carrier Proteins; Depression; Female; Headache; Humans; Imipramine; | 1991 |
Organic dissociative syndrome associated with antimigraine pharmacotherapy.
Topics: Adolescent; Analgesics; Aspirin; Barbiturates; Caffeine; Dissociative Disorders; Drug Combinations; | 1991 |
Migraine headache in the infant and young child.
Topics: Amitriptyline; Child, Preschool; Female; Humans; Imipramine; Infant; Male; Migraine Disorders; Ophth | 1990 |
[Normalization of sleep in migraine].
Topics: Circadian Rhythm; Electroencephalography; Humans; Imipramine; Migraine Disorders; Sleep; Sleep, REM | 1972 |